Ozempic

Marketing Tactics

The marketing strategies employed by Novo Nordisk for Ozempic and Wegovy reveal a complex web of tactics aimed at promoting these weight loss drugs. Aubrey Gordon and Michael Hobbes discuss the "It's Bigger Than Me" campaign, which suggests that obesity is a disease requiring medical treatment from Novo Nordisk. This campaign notably targets Black public figures, with spokespeople like Queen Latifah and Yvette Nicole Brown, to broaden its reach 1. Gordon criticizes the campaign for perpetuating harmful messages about body positivity and health, noting that it often repackages existing narratives to sell products 1.

The idea behind the campaign is, it's not your fault you're fat, followed immediately by it's because you have a disease, and that disease requires medical treatment.

--- Aubrey Gordon

The discussion highlights how these marketing practices set a template for discourse around weight loss drugs, influencing public perception and media narratives 2.

   

Media Bias

Media narratives surrounding Ozempic often reinforce existing biases and stigmas about obesity. Aubrey Gordon points out that headlines like "Ozempic settles the obesity debate" contribute to a wave of increased anti-fat bias, without addressing the needs of those affected by obesity or diabetes 3. The media's portrayal often fails to engage with the real experiences of fat people, perpetuating stereotypes and ignoring the complexities of weight loss and health 3.

What I am worried about is that when we see a wave of media like we have seen around Ozempic, we also tend to see a wave of increased anti-fat bias.

--- Aubrey Gordon

Michael Hobbes adds that the discourse around these drugs often overlooks the challenges of maintaining weight loss and the stigmatization of those who use them, calling for a more nuanced conversation 4.